Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H McCabe

Showing results (211-220 of 259) with videos related to

Pageof 26
Sort By:
Circulation|May 20, 2009
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarctionDavid A Morrow, Stephen D Wiviott, Harvey D White, et al.
Journal of the Neurological Sciences|July 23, 2013
Frequent inaccuracies in ABCD2 scoring in non-stroke specialists' referrals to a daily Rapid Access Stroke Prevention serviceDavid Bradley, Simon Cronin, Justin A Kinsella, et al.
The American Journal of Cardiology|February 1, 1997
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB)C P Cannon, C H McCabe, P H Stone, et al.
Neurology|March 8, 2013
Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patientsBettina von Sarnowski, Ulf Schminke, Turgut Tatlisumak, et al.
American Heart Journal|September 26, 2006
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)C Michael Gibson, Ajay J Kirtane, David A Morrow, et al.
American Heart Journal|June 30, 2000
First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trialsR P Giugliano, C H McCabe, R F Sequeira, et al.
Circulation|February 19, 1998
Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial InfarctionC P Cannon, C H McCabe, S Borzak, et al.
The New England Journal of Medicine|March 16, 2006
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarctionElliott M Antman, David A Morrow, Carolyn H McCabe, et al.
American Heart Journal|December 18, 2007
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trialDavid A Morrow, Yunmei Wang, Kevin Croce, et al.
The New England Journal of Medicine|November 6, 2007
Prasugrel versus clopidogrel in patients with acute coronary syndromesStephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, et al.
Pageof 26

Showing results (211-220 of 259) with videos related to

Sort By:
Pageof 26
Circulation|May 20, 2009
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarctionDavid A Morrow, Stephen D Wiviott, Harvey D White, et al.
Journal of the Neurological Sciences|July 23, 2013
Frequent inaccuracies in ABCD2 scoring in non-stroke specialists' referrals to a daily Rapid Access Stroke Prevention serviceDavid Bradley, Simon Cronin, Justin A Kinsella, et al.
The American Journal of Cardiology|February 1, 1997
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB)C P Cannon, C H McCabe, P H Stone, et al.
Neurology|March 8, 2013
Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patientsBettina von Sarnowski, Ulf Schminke, Turgut Tatlisumak, et al.
American Heart Journal|September 26, 2006
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)C Michael Gibson, Ajay J Kirtane, David A Morrow, et al.
American Heart Journal|June 30, 2000
First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trialsR P Giugliano, C H McCabe, R F Sequeira, et al.
Circulation|February 19, 1998
Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial InfarctionC P Cannon, C H McCabe, S Borzak, et al.
The New England Journal of Medicine|March 16, 2006
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarctionElliott M Antman, David A Morrow, Carolyn H McCabe, et al.
American Heart Journal|December 18, 2007
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trialDavid A Morrow, Yunmei Wang, Kevin Croce, et al.
The New England Journal of Medicine|November 6, 2007
Prasugrel versus clopidogrel in patients with acute coronary syndromesStephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, et al.
Pageof 26